OrfoNeuro ApS: Financial statements 2024
CVR: 37768901
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -199,417 and a net result of DKK -242,569 compared with DKK -208,111 the year before. Equity in the 2024 report amounted to DKK -1,050,091.
- Gross Profit
- DKK -199,417
- Profit/Loss
- DKK -242,569
- Equity
- DKK -1,050,091
- Total Assets
- DKK 27,651
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -199K | -243K | -1.1M | 0 |
| 2023 | - | -148K | -208K | -808K | 0 |
| 2022 | - | -90K | -95K | -599K | 0 |
| 2021 | - | -79K | -88K | -504K | 0 |
| 2020 | - | -155K | -153K | -416K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
OrfoNeuro ApS has published its annual report for 2023. Gross profit came to DKK -147,740, and the net result was DKK -208,111.
About OrfoNeuro ApS
OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.